Neoadjuvant Treatment of Nonfunctioning Pancreatic Neuroendocrine Tumors with [ <sup>177</sup> Lu-DOTA <sup>0</sup> ,Tyr <sup>3</sup> ]Octreotate - Concepedia

Concepedia

Publication | Open Access

Neoadjuvant Treatment of Nonfunctioning Pancreatic Neuroendocrine Tumors with [ <sup>177</sup> Lu-DOTA <sup>0</sup> ,Tyr <sup>3</sup> ]Octreotate

DOI Full Paper Access

120

Citations

19

References

2015

Year

Esther I. van Vliet, Casper H.J. van Eijck, Ronald R. de Krijger, E J Nieveen van Dijkum, Jaap J.M. Teunissen, Boen L. Kam, Wouter W. de Herder, Richard A. Feelders, Bert A. Bonsing, Tessa Brabander,

Journal of Nuclear Medicine

Abstract

Neoadjuvant treatment with (177)Lu-octreotate is a valuable option for patients with initially unresectable pancreatic NETs.

References

	Year	Citations

Page 1